Dressing is an intervention aimed to prevent infection in central venous catheter. This study aimed to analyze the frequency of catheter-related infection and skin toxicity in the use of transparent film in Hickman's catheter in patients who underwent allogeneic hematopoietic stem cell transplantation. A case series with 10 cases was carried out. Due to the presence of exudate on the average for 12 days, sterile gauze dressing was used for 12.9 days (average). Transparent film was used, on average, for 15.1 days. Catheters were precociously removed due to infection in four cases. The highest degree of skin toxicity occurred in a case that used gauze dressing and in three cases with film. The transparent film permitted visualization of the exit site of the catheter and changes with longer intervals. 
Introduction
The surgical implantation of an indwelling central venous catheter (CVC) is needed to perform hematopoietic stem cell transplantation (HSCT), and Hickman's catheter is indicated for most patients. That is the first preparatory action for HSCT, but the catheter's presence can cause complication, including infection caused by the rupture of the patient's skin integrity, which can lead to death (1) (2) (3) .
Placing a dressing on the CVC exit site aims to reduce catheter-related infection. A wide range of materials is used as CVC dressing. Literature reports on the use of the following materials: sterile gauze with adhesive tape, transparent polyurethane film, highly transpiration moisture permeable transparent polyurethane film and hydrocolloid dressing (4) (5) (6) .
Among advantages appointed for the use of transparent polyurethane film in indwelling catheter dressings for HSCT patients, longer dwelling time stands out, decreasing skin irritation manifested through local injuries, which cause discomfort and pain during dressing Rev. Latino-Am. Enfermagem 2010 Nov-Dec;18 (6) :1212-20.
change. Besides this aspect, there is evidence of greater satisfaction and better comfort from the patient's perspective, material cost reduction and decreased needs for the nursing team (7) (8) (9) . Despite these advantages, literature presents disagreement on the efficacy of transparent film. Some studies (6, (10) (11) evidenced no difference in infection incidence levels when comparing this type of dressing with the use of sterile gauze. Other studies (4, (12) (13) , on the other hand, appointed increased incidence of CVC-related infection when polyurethane dressings are used.
In Brazilian literature, two randomized and controlled clinical trials assessed the use of polyurethane dressing, but in peripheral venous catheters. In both studies, pediatric patients were divided in three groups:
transparent film, sterile gauze and adhesive tape and hypo-allergenic adhesive tape alone (14) (15) .
One study aimed to analyze the influence of the dressing type on the dwelling time of peripheral venous catheters. Its results appointed that the group that used sterile gauze dressings and adhesive tape showed a longer dwelling time for the device (14) . The other study identified the reasons for removal and adverse events related to the use of peripheral intravenous catheters in children according to the dressing types. The results demonstrated a statistically significant difference in the group with sterile gauze and adhesive tape regarding the decrease of adverse events like phlebitis, infiltration, folding of the device and accidental removal (15) .
It should also be highlighted that studies described in international literature (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) were conducted with funding from the pharmaceutical industry and in countries with a moderate climate. Thus, this study aims to assess the use of polyurethane dressing in Hickman's catheter in hospitalized patients in a tropical country with a warm and humid climate. This unedited research arouses concerns regarding the climate's possible influence on the dressing type's performance. This concern was also identified in Brazilian studies (14) (15) .
In view of the divergences detected in literature and the lack of Brazilian research, this study was conducted to develop research resulting in significant contributions to clinical nursing practice.
Aim
To analyze the frequency of catheter-related infection and skin toxicity in the use of polyurethane dressing on the exit site of Hickman's catheter implanted in allogeneic HSCT patients.
Material and method
This is a case series, which is a methodological option to test products or procedures. In this design, the sample is not randomly allocated and no control group is constituted, which makes it difficult to isolate the effect of the research intervention. The evidenced results can be confronted with literature, however, and provide evidence on the use and safety of the product or procedure under assessment (16) . (8) . The CVC-related infection was divided in exit site infection; tunnel infection and catheter-related bloodstream infection, which needs to be confirmed by a blood culture results, according to the CDC classification (17) . dressing is a source of concern, due to the risk of local proliferation of microorganisms (18) .
The trained nurses assessed signs and symptoms of skin toxicity daily at the dressing adhesion site and, in case of differences from the previous day, the data 
Results
The sample comprised 10 subjects, six (60%) women and four (40%) men. The average age was 41.9 years, ranging from 16 to 57 years. With regard to the baseline disease, four patients had leukemia, three myelodysplastic syndrome, two severe aplastic anemia and one Blackfan Diamond syndrome. Three deaths (30%) occurred during the hospitalization period. The median time passed between diagnosis and HSCT was eight months, ranging between two and 504 months.
The conditioning regimen fludarabine and busulphan was used in five cases, and the drug busulphan in seven cases.
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ISS -exit site infection; ICSRC -CVC-related bloodstream infection; ITS -subcutaneous tunnel infection
As shown in Table 3 , the average presence of erythema ≤2 cm on the CVC exit site was 13.5 days, and was absent in two cases; four cases presented erythema ≤2 cm before the application of the transparent polyurethane film and five on the day or after the application of the polyurethane dressing. As for edema and pain, their occurrence is low and happened on the first two post-operative days, except for one case when they persisted since the immediate post-operative until the removal of the CVC due to subcutaneous tunnel infection. Heat was observed in two cases, both of which developed CVC-related infection.
It is also appointed in Table 3 that the mean neutropenia period was 22.7 days and that four cases developed catheter-related infection (exit site infection, subcutaneous tunnel infection and bloodstream infection). In these cases, the mean CVC dwelling time was 20.2 days.
Discussion
Allogeneic HSCT implies greater infection risk due to the rupture of skin integrity as a result of the CVC implant, presence of prolonged neutropenia due to high
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chemotherapy doses, use of immunosuppressants in the prophylaxis of graft-against-host disease, besides the need for long catheter dwelling times (19) (20) .
In this study, on the average, the start of the conditioning regimen occurred two days after the catheter implant, although a study indicates that chemotherapeutic agents should not be administered until at least five to seven days after the surgery to avoid commitment of initial healing events (18) . These data differ from results evidenced in literature, which recommends dwelling times of more than seven days for transparent polyurethane film (7) (8) .
The highest degree of skin toxicity (degree 4) was observed in three cases when polyurethane dressings were used, against only one case for sterile gauze dressings with adhesive tape. It should be highlighted that the lesions mainly affected the adhesion site of the dressing borders.
In literature, studies on skin toxicity related to the adhesion of polyurethane dressing in HSCT patients have shown controversial results. In a clinical trial, the results evidenced a statistically significant difference, with lower skin toxicity in the group with a two-day change interval in comparison with the group where dressings were changed every five days (7) . On the other hand, a study that assessed 112 patients demonstrated a statistically significant difference in the reduction of skin toxicity for the group in which dressings were changed at longer intervals (study with the same research design as the abovementioned research). Among the 32 patients who presented skin toxicity degree ≥2, eight belonged to the group whose dressing was changed every 15 days and 24 to the group with dressing changes every four days (8) .
In a study of healthy individuals with simulation of repeated applications and removals of adhesive tape for dressings or intravascular catheter fixation on integral skin, the results demonstrated epidermal alterations, leading to irritation and many points of rupture in the stratum corneum (21) .
Besides this aspect, patients submitted to HSCT receive high doses of chemotherapeutic agents, which in most cases impede cell division for tissue repair.
Busulphan is an agent associated with systemic dermatological toxicity, predisposing to alterations like dermatitis, erythema, dryness and cutaneous fragility, contributing to the appearance of skin toxicity on the dressing adhesion site (8) .
In the present study, that drug was used in seven cases and, in five of these, patients presented some degree of cutaneous toxicity.
Local heat is related to the presence of an inflammatory process and an objective piece of data, obtained by palpating the exit site and subcutaneous tunnel. Polyurethane dressings impede this observation, functioning as an isolating thermal barrier, without allowing the evaluator to feel local temperature differences.
Exit site erythema is a characteristic attributed to exit site infection according to the CVC-related infection criteria recommended in CDC guidelines (17) to prevent intravascular catheter infection. In this study, a fact that can appoint this local infection was the early removal of four catheters due to CVC-related infection.
The period after the CVC implant can represent risk due to the skin trauma caused by the procedure and the delayed healing of patients submitted to HSCT, demonstrating the importance of catheter exit site care
for infection prevention and control, such as the dressing type (22) (23) . One preoccupying piece of information was the appearance of erythema ≤2 cm on the day or after the application of the polyurethane dressing in five cases.
In four cases under assessment, the CVC was removed On the opposite, in a retrospective study, it was identified that infection related to Hickman's catheter occurred in 10 patients (9.1%) submitted to allogeneic HSCT and, on the average, 32 days after the implant (D+31 -31 days after the infusion of hematopoietic stem cells). In the study, it is highlighted that Hickman catheter related infection was defined as the presence of erythema, edema, pain and/or purulent secretion on the exit site and/or in the subcutaneous tunnel associated with fever (22) . Also, the research indicated that the time for the myeloid grafting (confirmed by absolute neutrophil counts of more than 500 cells/mm 3 for three days in a row) was identified as the sole risk factor for Hickman's catheter infection, with an average 18 days for the grafting.
In the present study, six cases were admitted with neutropenia (absolute granulocyte counting ≤1000 cells/ In literature, recommendations to use polyurethane dressing is based on the following aspects: decreased manipulation of exit site, diminished cost and nursing time, besides promoting patients' comfort without increasing the intravascular catheter-related infection risk (6, (10) (11) . These research results diverge, however, hampering decision making in clinical practice.
In this sense, one study is observed that assessed three different type of short-term CVC dressings: sterile gauze with adhesive tape, transparent polyurethane film and highly transpiration moisture permeable transparent polyurethane film regarding the incidence of intravascular catheter-related bloodstream infection.
The results appointed a statistically significant difference in the reduction of CVC related infection with the use of highly transpiration moisture permeable transparent polyurethane film changed every 72 hours (24) .
On the opposite, in a randomized clinical trial conducted to compare common and highly transpiration moisture permeable transparent polyurethane film in short-term CVC, changed every 48 hours, the results evidenced similar quantities of fluid, microorganism growth in the skin culture and catheter-tip colonization among the dressing types (25) .
Hence, the recommendation to use transparent polyurethane film is controversial, mainly due to studies that demonstrated increased incidence of infection with a seven-day change interval (12) (13) .
The identification of Gram-positive microorganisms as causal agents of Hickman catheter-related infection
indicates that the local microbiota may be related in case of CVC contamination (22) (23) . This shows the importance of dressing care during the healing period and formation of fibrosis around the cuff with a view to catheter exit site infection prevention and control, as there seems to exist a relation with lumen and later bloodstream contamination.
Conclusions
The results evidenced in this case series To assess the efficacy of health interventions, it is known that the "gold standard" is experimental research development, such as randomized controlled clinical trials. In view of the type of patient under analysis, however, the researchers believe that this kind of study would only be possible in a multicenter study or during an extensive data collection period. Hence, they consider that, despite the study design used (case series), the present study results offer evidence that can contribute to nursing decision making in clinical practice as to what type of coverage needs to be used in tunneled indwelling CVC dressings.
